Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Combo Products Won't Get Special Review Pathway At US FDA Anytime Soon

Mar 22 2017

• By Michael Cipriano and Sue Darcey

Related Content

Combination Product Designations At US FDA Need Faster Appeals, Petition Says

Mar 13 2017

Risks Of Missing Reauthorization Deadline Highlighted At User-Fee Hearing

Mar 21 2017

Plan Carefully In Writing Combo Product Designation Requests, Experts Say

Dec 28 2015

Califf Supports Combo Products Pathway At Confirmation Hearing

Nov 17 2015

Combo Product Reforms Are A Priority For Next User Fee Round, FDA Officials Say

Jun 24 2015

Senate Bill Aimed At Streamlining Combo Product Regulation

Jul 20 2015

21st Century Cures: Device Provisions

Dec 01 2016

Combo Product Safety: US FDA Rule On Post-Market Reporting Nears Finalization

Dec 05 2016

Additional Topics

United States Policy Regulation Combination Products Medical Device

More from Combination Products

More from Device Area

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window